全球智库信息集成服务系统(G2TT): The role of pre-shipment batch testing in ensuring good medicine quality

G2TT

来源类型	Working Paper
规范类型	论文
	The role of pre-shipment batch testing in ensuring good medicine quality
	Roger Bate; Kimberly Hess
发表日期	2012-12-05
出版年	2012
语种	英语
摘要	Bate: The role of pre-shipment batch testing in ensuring good medicine quality Download PDF Most donor agencies only procure drugs approved by a Stringent Regulatory Authority or the World Health Organization (WHO) Prequalification Programme in an effort to ensure high quality. This study compares the quality of artemisinin-based combination therapies (ACTs) produced by WHO-approved manufacturers with non-approved manufacturers and suggests policy changes to improve quality of donor-procured drugs. The results of this study suggest that ACTs produced by WHO-approved manufacturers perform nearly five times better than those of non-approved manufacturers, but some approved ACTs have too little active pharmaceutical ingredient. The US President’s Malaria Initiative tests every batch of every drug it procures before distribution to recipient countries. Other donors should follow suit to ensure that drugs purchased with taxpayer dollars are of the highest quality. Download the PDF to read full paper here.
主题	Health Care
标签	developing countries ; drug safety ; Global health ; malaria
URL	https://www.aei.org/research-products/working-paper/the-role-of-pre-shipment-batch-testing-in-ensuring-good-medicine-quality/
来源智库	American Enterprise Institute (United States)
资源类型	智库出版物
条目标识符	http://119.78.100.153/handle/2XGU8XDN/207221
推荐引用方式 GB/T 7714	Roger Bate,Kimberly Hess. The role of pre-shipment batch testing in ensuring good medicine quality. 2012.

条目包含的文件
文件名称/大小	资源类型	版本类型	开放类型	使用许可
-bate-the-role-of-pr（128KB）	智库出版物		限制开放	CC BY-NC-SA	浏览